| Date Filed | Type | Description |
| 09/22/2022 |
4
| Islam Khalid (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2022 |
4
| Islam Khalid (Director) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 18,208 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Islam Khalid (Director) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 4,392 shares
@ $0 |
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
3
| Islam Khalid (Director) has filed a Form 3 on Gain Therapeutics, Inc. |
| 11/13/2020 |
3
| Islam Khalid (Director) has filed a Form 3 on Processa Pharmaceuticals, Inc. |
| 10/23/2020 |
4
| Islam Khalid (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Disposed/sold 13,516 shares
@ $0
Disposed/sold 52,614 options to buy
@ $0
Disposed/sold 3,718 restricted stock units
@ $0 |
|
| 08/14/2020 |
4
| Islam Khalid (Director) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 25,000 options to buy
@ $6.17, valued at
$154.3k
|
|
| 06/22/2020 |
4
| Islam Khalid (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 3,718 shares
@ $0
Granted 6,540 options to buy
@ $33.62, valued at
$219.9k
|
|
| 06/19/2019 |
4
| Islam Khalid (Director) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 25,000 options to buy
@ $4.26, valued at
$106.5k
|
|
| 06/11/2019 |
4
| Islam Khalid (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 9,667 shares
@ $0
Granted 17,077 options to buy
@ $12.93, valued at
$220.8k
|
|
| 09/19/2018 |
4
| Islam Khalid (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 3,849 shares
@ $0
Granted 6,497 options to buy
@ $14.29, valued at
$92.8k
|
|
| 06/11/2018 |
4
| Islam Khalid (Director) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 25,000 options to buy
@ $10.93, valued at
$273.3k
|
|
| 09/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/23/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |